114 related articles for article (PubMed ID: 9706130)
1. Modulation of matrix metalloproteinase activity in human saphenous vein grafts using adenovirus-mediated gene transfer.
Fernandez HA; Kallenbach K; Seghezzi G; Mehrara B; Apazidis A; Baumann FG; Grossi EA; Colvin S; Mignatti P; Galloway AC
Surgery; 1998 Aug; 124(2):129-36. PubMed ID: 9706130
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endothelial cell migration by gene transfer of tissue inhibitor of metalloproteinases-1.
Fernandez HA; Kallenbach K; Seghezzi G; Grossi E; Colvin S; Schneider R; Mignatti P; Galloway A
J Surg Res; 1999 Apr; 82(2):156-62. PubMed ID: 10090824
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein.
George SJ; Johnson JL; Angelini GD; Newby AC; Baker AH
Hum Gene Ther; 1998 Apr; 9(6):867-77. PubMed ID: 9581909
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3.
Kallenbach K; Salcher R; Heim A; Karck M; Mignatti P; Haverich A
J Vasc Surg; 2009 Mar; 49(3):750-8. PubMed ID: 19268777
[TBL] [Abstract][Full Text] [Related]
6. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.
Kranzhöfer A; Baker AH; George SJ; Newby AC
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):255-65. PubMed ID: 9974405
[TBL] [Abstract][Full Text] [Related]
7. Loss of Endothelial Barrier in Marfan Mice (mgR/mgR) Results in Severe Inflammation after Adenoviral Gene Therapy.
Seppelt PC; Schwill S; Weymann A; Arif R; Weber A; Zaradzki M; Richter K; Ensminger S; Robinson PN; Wagner AH; Karck M; Kallenbach K
PLoS One; 2016; 11(2):e0148012. PubMed ID: 26840980
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3.
George SJ; Lloyd CT; Angelini GD; Newby AC; Baker AH
Circulation; 2000 Jan; 101(3):296-304. PubMed ID: 10645926
[TBL] [Abstract][Full Text] [Related]
9. Recombinant endothelial nitric oxide synthase-transduced human saphenous veins: gene therapy to augment nitric oxide production in bypass conduits.
Cable DG; O'Brien T; Schaff HV; Pompili VJ
Circulation; 1997 Nov; 96(9 Suppl):II-173-8. PubMed ID: 9386094
[TBL] [Abstract][Full Text] [Related]
10. Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1.
Wolff RA; Ryomoto M; Stark VE; Malinowski R; Tomas JJ; Stinauer MA; Hullett DA; Hoch JR
J Vasc Surg; 2005 Mar; 41(3):498-508. PubMed ID: 15838486
[TBL] [Abstract][Full Text] [Related]
11. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
[TBL] [Abstract][Full Text] [Related]
12. Peptide-retargeted adenovirus encoding a tissue inhibitor of metalloproteinase-1 decreases restenosis after intravascular gene transfer.
Turunen MP; Puhakka HL; Koponen JK; Hiltunen MO; Rutanen J; Leppänen O; Turunen AM; Närvänen A; Newby AC; Baker AH; Ylä-Herttuala S
Mol Ther; 2002 Sep; 6(3):306-12. PubMed ID: 12231165
[TBL] [Abstract][Full Text] [Related]
13. Expression of metalloproteinases and its inhibitor in later stage of rabbit neointima development.
Wang H; Liu C; Song Y; Gordon D; Alavi MZ; Moore S
Int J Mol Med; 2001 Jan; 7(1):105-12. PubMed ID: 11115618
[TBL] [Abstract][Full Text] [Related]
14. Adventitial delivery minimizes the proinflammatory effects of adenoviral vectors.
Schneider DB; Sassani AB; Vassalli G; Driscoll RM; Dichek DA
J Vasc Surg; 1999 Mar; 29(3):543-50. PubMed ID: 10069919
[TBL] [Abstract][Full Text] [Related]
15. [Effects of tissue inhibitor of matrix metalloproteinases-4 on the activities of matrix metalloproteinases and collagen of artery: experiment with rats].
Zu LY; Guo YH; Chen L; Li Q; Yan H; Gao W
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):472-5. PubMed ID: 16677575
[TBL] [Abstract][Full Text] [Related]
16. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
[TBL] [Abstract][Full Text] [Related]
17. [Co-overexpression of human tissue kallikrein 1 and human metalloproteinase 1 tissue inhibitor inhibits neointima formation in the rat artery after balloon angioplasty].
Yu HZ; Zhang F; Zhu PL; Pan W; Huang SJ; Xiang H
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 May; 44(5):436-42. PubMed ID: 27220581
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts.
Chen SJ; Wilson JM; Muller DW
Circulation; 1994 May; 89(5):1922-8. PubMed ID: 7514108
[TBL] [Abstract][Full Text] [Related]
19. Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cells.
Baker AH; Wilkinson GW; Hembry RM; Murphy G; Newby AC
Matrix Biol; 1996 Dec; 15(6):383-95. PubMed ID: 9049977
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated expression of TIMP-1 and TIMP-2 in bone inhibits osteolytic degradation by human prostate cancer.
Deng X; He G; Levine A; Cao Y; Mullins C
Int J Cancer; 2008 Jan; 122(1):209-18. PubMed ID: 17847032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
